Drug Pricing Reform on the Back Burner in Ramp-Up to US Mid-Term Elections
November 7, 2022
Although healthcare is front and center on tomorrow’s ballot in terms of abortion and Medicare, drug pricing reform has not been a key talking point in the lead-up to the US mid-term elections. This is in spite of the Democrats’ recent legislative win with the Inflation Reduction Act, which included major drug pricing reform. However, some Republicans hope to completely or partially repeal the act, including popular portions like price capping prescription costs for older adults.
According to , “This summer, Democrats had hoped to hammer Republicans on a vote to strip insulin cost protections for patients with private insurance from their domestic spending bill, but Senate Majority Leader Chuck Schumer (D-N.Y.) ultimately backed off promises to force Republicans to vote on the policy, so the issue has faded from mind for many candidates. The insulin cost cap bill was formally led by Sen. Raphael Warnock, a Georgia Democrat facing one of the most competitive races in the country.”
To read more, click here.
(Source: STAT News, November 7th, 2022)
